Fuchs’ Uveitis Syndrome and Glaucoma

  • Edney R. Moura Filho
  • Thomas J. Liesegang


Lawrence first described Fuchs’ uveitis syndrome (FUS) in 1843. In 1906, in a series of 38 patients, Ernst Fuchs’ described a condition called complicated heterochromia, which was characterized by heterochromia, inflammation, and cataract. This disorder has also been called Fuchs’ heterochromic uveitis and Fuchs’ heterochromic cyclitis. However, vitreous opacities and chorioretinal scars are common, and therefore the frequently used term cyclitis is not entirely accurate.


Cataract Surgery Rubella Virus Corneal Edema Secondary Glaucoma Argon Laser Trabeculoplasty 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Lawrence W. Changes in colour in the iris. In: Hays I, ed. A Treatise on Diseases of the Eye. Philadelphia: Lea & Blauchard; 1853:411–416.Google Scholar
  2. 2.
    Fuchs E. Ueber komplikationen der Heterochromie. Z Augenheilkd. 1906;15:191–212.Google Scholar
  3. 3.
    Mohamed Q, Zamir E. Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol. 2005;16:356–363.CrossRefPubMedGoogle Scholar
  4. 4.
    Franceschetti A. Heterochromic cyclitis (Fuchs’ syndrome). Am J Ophthalmol.. 1955;39:50–58.PubMedGoogle Scholar
  5. 5.
    Kimura SJ. Fuchs’ syndrome of heterochromic cyclitis in brown-eyed patients. Trans Am Ophthalmol Soc. 1978;76:76–89.PubMedGoogle Scholar
  6. 6.
    Lowenfield IE, Thompsom S. Fuchs’ heterochromic cyclitis. A critical review of the literature. I. Clinical characteristics of the syndrome. Surv Ophthalmol. 1973;17:394–457.Google Scholar
  7. 7.
    Lowenfield IE, Thompsom S. Fuchs’ heterochromic cyclitis. A critical review of the literature. I. Etiology and mechanisms. Surv Ophthalmol. 1973;18:2–61.Google Scholar
  8. 8.
    Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol. 1994;18:293–298.CrossRefPubMedGoogle Scholar
  9. 9.
    Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234–235.PubMedGoogle Scholar
  10. 10.
    Liesegang TJ. Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol. 1982;100:1622–1626.PubMedGoogle Scholar
  11. 11.
    Jones NP. Fuchs’ heterochromic uveitis: a reappraisal of the clinical spectrum. Eye. 1991;5:649–661.PubMedGoogle Scholar
  12. 12.
    Liesegang TJ. Fuchs uveitis syndrome. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection & Immunity. St Louis: Mosby; 1996:495–506.Google Scholar
  13. 13.
    Jones NP. Glaucoma in Fuchs’ heterochromic uveitis: aetiology, management and outcome. Eye. 1991;5:662–667.PubMedGoogle Scholar
  14. 14.
    Jones NP. Fuchs’ heterochromic uveitis: an update. Surv Ophthalmol. 1993;37:253–272.CrossRefPubMedGoogle Scholar
  15. 15.
    Tabbut BR, Tessler HH, Williams D. Fuchs’ heterochromic iridocyclitis in blacks. Arch Ophthalmol. 1988;106:1688–1690.PubMedGoogle Scholar
  16. 16.
    Jain IS, Gupta A, Gangwar DN, Dhir SP. Fuchs’ heterochromic cyclitis: some observations on clinical picture and on cataract surgery. Ann Ophthalmol. 1983;15:640–642.PubMedGoogle Scholar
  17. 17.
    O’Connor GR. Heterocromic iridocyclitis. Doyne lecture. Trans Ophthalmol Soc UK. 1985;104:219–231.PubMedGoogle Scholar
  18. 18.
    Donoso LA, Eigerman RA, Magargal LE. Fuchs’ heterochromic cyclitis associated with subclavian steal syndrome. Ann Ophthalmol. 1981;13:1153–1155.PubMedGoogle Scholar
  19. 19.
    Clarnella-Cantani A. and Leonardi E. Bilateral Fuchs’s syndrome of heterochromic cyclitis. Clin Oculist Patol Oculare. 1982;3:91–94.Google Scholar
  20. 20.
    La Hey E, Baarsma GS, de Vries J, Kijlstra A. Clinical analysis of Fuchs’ heterochromic cyclitis. Documenta Ophtalmologica. 1991;78:225–235.CrossRefGoogle Scholar
  21. 21.
    La Hey E, Ijspeert JK, van den Berg TJ, Kijlstra A. Quantitative analysis of iris translucency in Fuchs’ heterochromic cyclitis. Invest Ophthalmol Vis Sci. 1993;34:2931–2942.PubMedGoogle Scholar
  22. 22.
    Zamir E, Margalit E, Chowers I. Iris crystals in Fuchs’ heterochromic iridocyclitis. Arch Ophthalmol. 1998;116:1394.PubMedGoogle Scholar
  23. 23.
    Callear AB, Reynolds A, Harry J, Murray PI. Iris crystals in chronic uveitis. Br J Ophthalmol. 1999;83:703.CrossRefPubMedGoogle Scholar
  24. 24.
    Lam S, Tessler HH, Winchester K, et al. Iris crystals in chronic iridocyclitis. Br J Ophthalmol. 1993;77:181–182.CrossRefPubMedGoogle Scholar
  25. 25.
    Norrsell K, Holmer AK, Jacobson H. Aqueous flare in patients with monocular iris atrophy and uveitis: a laser flare and iris angiography study. Acta Ophthalmol Scand. 1998;76(4):405–412.CrossRefPubMedGoogle Scholar
  26. 26.
    Feldman ST, Deutsch TA. Hyphema following Honan balloon use in Fuchs’ heterochromic iridocyclitis. Arch Ophthalmol. 1986;104:967.PubMedGoogle Scholar
  27. 27.
    Ward DM, Hart CT. Complicated cataract extraction in Fuchs’s heterochromic uveitis. Br J Ophthalmol. 1967;51:530–538.CrossRefPubMedGoogle Scholar
  28. 28.
    Kimura SJ, Hogan MJ, Thygeson P. Fuchs’ Syndrome of Heterochromic cyclitis. Arch Ophthalmol. 1955;54:179–186.Google Scholar
  29. 29.
    De Abreu MT, Belfort R, Hirata PS. Fuchs’ heterochromic cyclitis and ocular toxoplasmosis. Am J Ophthalmol. 1982;93:739–742.Google Scholar
  30. 30.
    La Hey E, Rothova A, Baarsma GS, de Vries J, van Knapen F, Kijlstra A. Fuchs’ heterochromic iridocyclitis is not associated with ocular toxoplasmosis. Arch Ophthalmol. 1992;110(6):806–811.PubMedGoogle Scholar
  31. 31.
    Melamed S, Lahav M, Sandbank U, et al. Fuchs’ heterochromic iridocyclitis, an electron microscopic study of the iris. Invest Ophthalmol Vis Sci. 1978;17:1193–1198.PubMedGoogle Scholar
  32. 32.
    Aggarwal RK, Luck J, Coster DJ. Horner’s syndrome and Fuchs’ heterochromic uveitis. Br J Ophthalmol. 1994;78(12):949.CrossRefPubMedGoogle Scholar
  33. 33.
    La Hey E, Baarsma GS, Rothova A, et al. High incidence of corneal epithelium antibodies in Fuchs’ heterochromic cyclitis. Br J Ophthalmol. 1988;72:921–925.CrossRefPubMedGoogle Scholar
  34. 34.
    Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138:46–54.CrossRefPubMedGoogle Scholar
  35. 35.
    Birnbaum AD, Tessler HH, Schultz KA, et al. Epidemiological relationship between Fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol. 2007;144:424–428.CrossRefPubMedGoogle Scholar
  36. 36.
    Kitaichi N, Ariga T, Ohno S, Shimizu T. Acute unilateral conjunctivitis after rubella vaccination: the detection of the rubella genome in the inflamed conjunctiva by reverse transcriptase-polymerase-chain reaction. Br J Ophthalmol. 2006;90:1436–1437.CrossRefPubMedGoogle Scholar
  37. 37.
    Islam SM, El-Sheikh HF, Tabbara KF. Anterior uveitis following combined vaccination for measles, mumps, and rubella (MMR): a report of two cases. Acta Ophthalmol Scand. 2000;78:590–592.CrossRefPubMedGoogle Scholar
  38. 38.
    Amsler M, Verrey F. Heterochromie de Fuchs et fragilite vasculaire. Ophthalmologica. 1946;111:177.CrossRefPubMedGoogle Scholar
  39. 39.
    Huber A. Das Glaucom bei komplizierten Hetcrochromie Fuchs. Ophthalmologica. 1961;142:66–115.CrossRefPubMedGoogle Scholar
  40. 40.
    Chandler PA, Grant WM. Lectures on Glaucoma. Philadelphia: Lea and Febiger; 1965.Google Scholar
  41. 41.
    Benedikt O, Roll P, Zirm M. The glaucoma in heterochromic cyclitis of Fuchs. Gonioscopic studies and electron microscopic investigations of the trabecular meshwork. Klin Monatsbl Augenheilkd. 1978;173:523–533.PubMedGoogle Scholar
  42. 42.
    Berger BB, Tessler HH, Kottow MH. Anterior segment ischaemia in Fuchs’ heterochromic cyclitis. Arch Ophthalmol. 1980;98:499–501.PubMedGoogle Scholar
  43. 43.
    Hart CT. The IOP in Fuch’s heterochromic cyclitis. Trans Ophthalmol Soc UK. 1971;91:771–775.PubMedGoogle Scholar
  44. 44.
    Hart CT, Ward DM. Intraocular pressure in Fuchs’s heterochromic uveitis. Br J Ophthalmol. 1967;51:739–743.CrossRefPubMedGoogle Scholar
  45. 45.
    Lerman S, Levy C. Heterochromic iritis and secondary neovascular glaucoma. Am J Ophthalmol. 1964;57:479–481.PubMedGoogle Scholar
  46. 46.
    Perry HD, Yanoff M, Scheie HG. Rubeosis in Fuchs heterochromic iridocyclitis. Arch Ophthalmol. 1975;93:337–339.PubMedGoogle Scholar
  47. 47.
    Lemke L. Das Glaucoma bei Heterochromiecyclitis. Ophthalmologica. 1966;151:457–464.CrossRefPubMedGoogle Scholar
  48. 48.
    Pietruschka G, Priesz G. Secondary glaucoma with heterochromia cyclitis according to Fuchs. Klin Monatsbl Augenheilkd. 1974;164:609–615.PubMedGoogle Scholar
  49. 49.
    Norn MS. Cataract extraction in Fuchs’ heterochromia: follow-up of 19 cases. Acta Ophthalmologica. 1968;46:685–699.CrossRefPubMedGoogle Scholar
  50. 50.
    La Hey E, de Vries J, Langerhorst CT, et al. Treatment and prognosis of secondary glaucoma in Fuchs’ heterochromic iridocyclitis. Am J Ophthalmol. 1993;116:327–340.PubMedGoogle Scholar
  51. 51.
    Merayo-Lloves J, Power WJ, Rodriguez A, et al. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999;213:300–304.CrossRefPubMedGoogle Scholar
  52. 52.
    Stavrou P, Murray PI. Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol. 1999;128:434–439.CrossRefPubMedGoogle Scholar
  53. 53.
    Towler HMA, Bates AK, Broadway DC, et al. Primary trabeculectomy with 5 fluorouracil for glaucoma secondary to uveitis. Ocul Immunol Inflamm. 1995;3:163–170.CrossRefGoogle Scholar
  54. 54.
    Towler HM, McCluskey P, Shaer B, et al. Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology. 2000;107:1822–1828.CrossRefPubMedGoogle Scholar
  55. 55.
    Jampel HD, Jabs DA, Quigley HA. Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol. 1990;109:168–173.PubMedGoogle Scholar
  56. 56.
    Sung VC, Barton K. Management of inflammatory glaucomas. Curr Opin Ophthalmol. 2004;15:136–140.CrossRefPubMedGoogle Scholar
  57. 57.
    Molteno, AC, Sayawat N, Herbison, P. Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology. 2001;108:605-613.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Edney R. Moura Filho
    • 1
  • Thomas J. Liesegang
    • 2
  1. 1.Mayo ClinicJacksonvilleUSA
  2. 2.Department of OphthalmologyMayo ClinicJacksonvilleUSA

Personalised recommendations